Disposable Endoscopes Market worth $2.67 billion by 2030 with 22.9% CAGR | MarketsandMarkets Trademark

Browse 250 market data Tables and 60 Figures spread through 350 Pages and in-depth TOC on "Disposable Endoscopes Market by Type (GI Endoscopes, Urology Endoscopes, Laryngoscopes), Clinical Usage (Diagnostic, Surgical), Application (Urology, Gastroenterology, ENT Endoscopy), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030
The global Disposable Endoscopes Market [https://www.marketsandmarkets.com/Market-Reports/disposable-endoscopes-market-14518319.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=disposableendoscopesmarket], valued at US$0.84 billion in 2024, stood at US$0.95 billion in 2025 and is projected to advance at a resilient CAGR of 22.9% from 2025 to 2030, culminating in a forecasted valuation of US$2.67 billion by the end of the period. The disposable endoscopes market is expanding due to increasing demand for minimally invasive procedures, a rising prevalence of chronic diseases such as neurological and respiratory disorders, and technological advancements that improve image quality and maneuverability. Additionally, the growing geriatric population and better reimbursement policies further encourage adoption. However, market growth is limited by high device costs, the risk of cross-contamination despite reprocessing, and the availability of alternative diagnostic techniques.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14518319 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14518319&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=disposableendoscopesmarket]

By type, the disposable endoscopes market is segmented into urology endoscopes, bronchoscopes, cystoscopes, laryngoscopes, GI endoscopes, arthroscopes, and other disposable endoscopes. Among these, the urology endoscopes segment held the largest market share in 2024, due to the rising prevalence of chronic kidney and ureteral diseases, along with increasing incidences of prostate disorders. Urology endoscopes, including ureteroscopes, nephroscopes, resectoscopes, and urethroscopes, are widely used for diagnosing and treating these conditions. According to the Centers for Disease Control and Prevention (CDC), as of 2023, more than 1 in 7 U.S. adults-about 35.5 million people-are estimated to have chronic kidney disease (CKD). Additionally, the American Cancer Society projects around 313,780 new cases and 35,770 deaths from prostate cancer in 2025. The increasing procedural volume, combined with infection control benefits and the ease of use of disposable urology endoscopes, drives their dominant market share.

By end user, the disposable endoscopes market is segmented into hospitals, ambulatory surgical centers, clinics, and other end users such as diagnostic centers, mobile endoscopy facilities, and office-based endoscopy service providers. Among these, the hospital segment held the largest market share in 2024 due to the high volume of diagnostic and therapeutic procedures performed within hospital settings. Hospitals serve as primary centers for advanced and complex endoscopic interventions across specialties like gastroenterology, urology, and pulmonology. The availability of skilled healthcare professionals, advanced infrastructure, and robust infection control protocols supports the adoption of disposable endoscopes to reduce cross-contamination risks. Additionally, hospitals increasingly prefer single-use endoscopes to avoid the costs and operational challenges of cleaning and reprocessing reusable scopes. The growing patient influx, rising chronic disease burden, and increased awareness of infection prevention further reinforce hospitals' dominant role in driving disposable endoscope use globally.

By geography, the disposable endoscopes market is divided into five main regional segments: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America held the largest share of the global disposable endoscopes market. The region's growth is driven by the high prevalence of chronic diseases, an aging population, and rising procedural volumes across various specialties. According to the U.S. Census Bureau, the population aged 65 and older increased by 3.1% from 2023 to 2024, boosting demand for diagnostic and therapeutic procedures. The Centers for Disease Control and Prevention (CDC) reported that over 35.5 million U.S. adults have chronic kidney disease, while the American Cancer Society projects 2,041,910 new cancer cases in 2025, including 313,780 prostate cancer cases. Additionally, more than one million cystoscopy procedures are performed annually in the U.S. The presence of major companies like Ambu A/S and Boston Scientific, along with FDA initiatives promoting infection prevention through single-use endoscopes, further reinforces North America's market leadership.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=14518319 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=14518319&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=disposableendoscopesmarket]

Some of the prominent players operating in the market include Olympus Corporation (Japan), Boston Scientific Corporation (US), HOYA Corporation (Japan), Ambu A/s (Denmark), Karl Storz SE & Co. KG (Germany), Hunan Vathin Medical Instrument Co., Ltd. (China), Scivita Medical (China), and Innovex Medical Co., Ltd. (China).

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=disposable-endoscopes-market-worth-267-billion-by-2030-with-229-cagr-marketsandmarkets]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/disposable-endoscopes-market-14518319.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.